Diastolic dysfunction in alveolar hypoxia: A role for interleukin-18- mediated increase in protein phosphatase 2A

Cardiovascular Research

Volumn 80, Issue 1, 2008, Pages 47-54

  Larsen, Karl Otto ^a,b   Lygren, Birgitte ^b   Sjaastad, Ivar ^a,b   Krobert, Kurt A ^b   Arnkværn, Kristin ^a,b   Florholmen, Geir ^a,b   Larsen, Ann Kristin Ruud ^a   Levy, Finn Olav ^b   Taskén, Kjetil ^b   Skjønsberg, Ole Henning ^a   Christensen, Geir ^a,b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Cytokines; Hypoxia; Phospholamban; Protein phosphatases

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOKINE; INTERLEUKIN 18; OXYGEN; PHOSPHOLAMBAN; PHOSPHOPROTEIN PHOSPHATASE 2A; SERINE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; C57BL 6 MOUSE; CELL ISOLATION; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; HEART; HEART MUSCLE; HEART MUSCLE CELL; HYPOXIA; LUNG ALVEOLUS HYPOXIA; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SARCOPLASMIC RETICULUM; SERUM;

EID: 51749118537     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvn180     Document Type: Article

References (39)

1. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-1012.
2. Baum GL, Schwartz A, Llamas R, Castillo C. Left ventricular function in chronic obstructive lung disease. N Engl J Med 1971;285:361-365.
3. Larsen KO, Sjaastad I, Svindland A, Krobert KA, Skjønsberg OH, Christensen G. Alveolar hypoxia induces left ventricular diastolic dysfunction and reduces phosphorylation of phospholamban in mice. Am J Physiol Heart Circ Physiol 2006;291:H507-H516.
4. Levi M, Moons L, Bouche A, Shapiro SD, Collen D, Carmeliet P. Deficiency of urokinase-type plasminogen activator-mediated plasmin generation impairs vascular remodeling during hypoxia-induced pulmonary hypertension in mice. Circulation 2001;103:2014-2020.
5. Kapiloff MS, Jackson N, Airhart N. mAKAP and the ryanodine receptor are part of a multi-component signaling complex on the cardiomyocyte nuclear envelope. J Cell Sci 2001;114:3167-3176.
6. 2+ re-uptake into heart sarcoplasmic reticulum. EMBO Rep 2007;8:1061-1067.
7. Iona S, Cuomo M, Bushnik T, Naro F, Sette C, Hess M et al. Characterization of the rolipram-sensitive, cyclic AMP-specific phosphodiesterases: identification and differential expression of immunologically distinct forms in the rat brain. Mol Pharmacol 1998;53:23-32.
8. 2+-exchanger in normal and detubulated rat cardiomyocytes. J Mol Cell Cardiol 2003;35:1325-1337.
9. Braz JC, Gregory K, Pathak A, Zhao W, Sahin B, Klevitsky R et al. PKC-α regulates cardiac contractility and propensity toward heart failure. Nat Med 2004;10:248-254.
10. 7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution. Naunyn Schmiedebergs Arch Pharmacol 2001;363:620-632.
11. Florholmen G, Andersson KB, Yndestad A, Austbø B, Henriksen UL, Christensen G. Leukaemia inhibitory factor alters expression of genes involved in rat cardiomyocyte energy metabolism. Acta Physiol Scand 2004;180:133-142.
12. El Armouche A, Rau T, Zol kO, Ditz D, Pamminger T, Zimmermann WH et al. Evidence for protein phosphatase inhibitor-1 playing an amplifier role in β-adrenergic signaling in cardiac myocytes. FASEB J 2003;17:437-439.
13. El Armouche A, Bednorz A, Pamminger T, Ditz D, Didie M, Dobrev D et al. Role of calcineurin and protein phosphatase-2A in the regulation of phosphatase inhibitor-1 in cardiac myocytes. Biochem Biophys Res Commun 2006;346:700-706.
14. Yamada N, Niwa S, Tsujimura T, Iwasaki T, Sugihara A, Futani H et al. Interleukin-18 and interleukin-12 synergistically inhibit osteoclastic bone-resorbing activity. Bone 2002;30:901-908.
15. Nguyen SV, Claycomb WC. Hypoxia regulates the expression of the adrenomedullin and HIF-1 genes in cultured HL-1 cardiomyocytes. Biochem Biophys Res Commun 1999;265:382-386.
16. Krankel N, Adams V, Gielen S, Linke A, Erbs S, Schuler G et al. Differential gene expression in skeletal muscle after induction of heart failure: impact of cytokines on protein phosphatase 2A expression. Mol Genet Metab 2003;80:262-271.
17. s-coupled receptors in adult rat ventricular myocytes. Circ Res 2006;98:1081-1088.
18. Colston JT, Boylston WH, Feldman MD, Jenkinson CP, de la Rosa SD, Barton A et al. Interleukin-18 knockout mice display maladaptive cardiac hypertrophy in response to pressure overload. Biochem Biophys Res Commun 2007;354:552-558.
19. Woldbaek PR, Sande JB, Strømme TA, Lunde PK, Djurovic S, Lyberg T et al. Daily administration of interleukin-18 causes myocardial dysfunction in healthy mice. Am J Physiol Heart Circ Physiol 2005;289:H708-H714.
20. Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG. An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 2005;122:261-273.
21. Boussuges A, Pinet C, Molenat F, Burnet H, Ambrosi P, Badier M et al. Left atrial and ventricular filling in chronic obstructive pulmonary disease. An echocardiographic and Doppler study. Am J Respir Crit Care Med 2000;162:670-675.
22. 16 phosphorylated phospholamban in the failing rat myocardium: a major contributor to reduced SERCA2 activity. Cardiovasc Res 2002;53:382-391.
23. Satoh S, Ueda Y, Suematsu N, Oyama J, Kadokami T, Sugano M et al. Beneficial effects of angiotensin-converting enzyme inhibition on sarcoplasmic reticulum function in the failing heart of the Dahl rat. Circ J 2003;67:705-711.
24. Tasken K, Aandahl EM. Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol Rev 2004;84:137-167.
25. Kirchhefer U, Baba HA, Boknik P, Breeden KM, Mavila N, Bruchert N et al. Enhanced cardiac function in mice overexpressing protein phosphatase inhibitor-2. Cardiovasc Res 2005;68:98-108.
26. Gergs U, Boknik P, Buchwalow I, Fabritz L, Matus M, Justus I et al. Overexpression of the catalytic subunit of protein phosphatase 2A impairs cardiac function. J Biol Chem 2004;279:40827-40834.
27. Taylor BK, Stoops TD, Everett AD. Protein phosphatase inhibitors arrest cell cycle and reduce branching morphogenesis in fetal rat lung cultures. Am J Physiol Lung Cell Mol Physiol 2000;278:L1062-L1070.
28. Xue C, Heller F, Johns RA, Everett AD. Developmental expression and localization of the catalytic subunit of protein phosphatase 2A in rat lung. Dev Dyn 1998;211:1-10.
29. Everett AD, Kamibayashi C, Brautigan DL. Transgenic expression of protein phosphatase 2A regulatory subunit B56γ disrupts distal lung differentiation. Am J Physiol Lung Cell Mol Physiol 2002;282: L1266-L1271.
30. Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J 2006;28:1245-1257.
31. Prabhu SD. Cytokine-induced modulation of cardiac function. Circ Res 2004;95:1140-1153.
32. Imaoka H, Hoshino T, Takei S, Kinoshita T, Okamoto M, Kawayama T et al. Interleukin-18 production and pulmonary function in COPD. Eur Respir J 2008;31:287-297.
33. Cameron LA, Taha RA, Tsicopoulos A, Kurimoto M, Olivenstein R, Wallaert B et al. Airway epithelium expresses interleukin-18. Eur Respir J 1999;14:553-559.
34. Kim J, Shao Y, Kim SY, Kim S, Song HK, Jeon JH et al. Hypoxia-induced IL-18 increases hypoxia-inducible factor-1a expression through a Rac1-dependent NF-κB pathway. Mol Biol Cell 2008;19:433- 444.
35. Woldbaek PR, Tønnessen T, Henriksen UL, Florholmen G, Lunde PK, Lyberg T et al. Increased cardiac IL-18 mRNA, pro-IL-18 and plasma IL-18 after myocardial infarction in the mouse; a potential role in cardiac dysfunction. Cardiovasc Res 2003;59:122-131.
36. Seta Y, Kanda T, Tanaka T, Arai M, Sekiguchi K, Yokoyama T et al. Interleukin-18 in patients with congestive heart failure: induction of atrial natriuretic peptide gene expression. Res Commun Mol Pathol Pharmacol 2000;108:87-95.
37. Kass DA, Bronzwaer JG, Paulus WJ. What mechanisms underlie diastolic dysfunction in heart failure? Circ Res 2004;94:1533-1542.
38. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998;93:215-228.
39. Koulmann N, Novel-Chate V, Peinnequin A, Chapot R, Serrurier B, Simler N et al. Cyclosporin A inhibits hypoxia-induced pulmonary hypertension and right ventricle hypertrophy. Am J Respir Crit Care Med 2006;174:699-705.